Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03318939 |
|---|---|
| Brief Title: | Phase 2 Study of Poziotinib in Patients With NSCLC Having EGFR or HER2 Exon 20 Insertion Mutation |
| First Submitted : | October 10, 2017 |
| First Submitted that Met QC Criteria : | October 20, 2017 |
| First Posted : | October 24, 2017 |
| Last Update Submitted that Met QC Criteria : | February 24, 2022 |
| Last Update Posted : | February 28, 2022 |